首页> 外文期刊>Advanced functional materials >BPA-Containing Polydopamine Nanoparticles for Boron Neutron Capture Therapy in a U87 Glioma Orthotopic Model
【24h】

BPA-Containing Polydopamine Nanoparticles for Boron Neutron Capture Therapy in a U87 Glioma Orthotopic Model

机译:BPA-Containing Polydopamine Nanoparticles for Boron Neutron Capture Therapy in a U87 Glioma Orthotopic Model

获取原文
获取原文并翻译 | 示例
           

摘要

Boron neutron capture therapy (BNCT) is a promising therapy for refractorycancer based on the cytotoxic reaction of ~(10)B (n, α) ~7Li. Although two BNCTagents are clinically available, they are quickly metabolized and show modestenrichment in tumor sites, partially limiting BNCT widespread application.Consequently, novel agents that perform active targeting and show good biocompatibilityhave to be developed. Herein, boronophenylalanine-containingpolydopamine (B-PDA) nanoparticles are easily fabricated by encapsulatingboronophenylalanine (BPA) in polydopamine via nitrogen-boronate coordination.In this study, B-PDA achieves increased tumor accumulation and prolongedretention effects in the tumor site and superior antitumor activity postneutron irradiation in the orthotopic xenograft glioma model. In brief, thisstudy offers a novel strategy for BPA delivery and may broaden the perspectiveon nanomedicine design for BNCT.

著录项

获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号